Release Date: 04/03/20 14:44 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 195.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%